Peptide RX

back to claim graph

proof receipt / target

CAMP-LL37

Cathelicidin antimicrobial peptide (LL-37 precursor)

grade B status immune_resilience receipt 4823cea11ffc proof 33%

what this node claims

CAMP-LL37

Cathelicidin antimicrobial peptide (LL-37 precursor)

Open source surface

vertical proof spine

  1. 01 CAMP-LL37 target / grade B / 70% 1 debt
  2. 02 CAMP WT fold / grade B / 64% 2 debt

evidence / risk instrument

44%
thin proof
structure evidence gates risk export lineage 44
low debt pressure 21%
28%structuredebt
pLDDT pending
78%evidenceusable
grade B
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine

proof completeness

33% missing alphafold_metric, candidate, finding, export
  1. 01 target
  2. 02 fold
  3. 03 alphafold metric
  4. 04 candidate
  5. 05 finding
  6. 06 export

Metrics and receipt inputs

binding partners
    context annotations
    0
    family
    antimicrobial_peptide
    functional sites
      gene symbol
      CAMP
      go terms
        uniprot
        P49913

        AlphaFold metrics visual

        Confident backbone model

        80.0

        170 residues / min 38.31 / max 98.12 / source alphafold db

        PAE matrix for linked target
        Very high 42.9% 73 residues / >=90
        Confident 27.6% 47 residues / 70-89
        Low 27.6% 47 residues / 50-69
        Very low 1.8% 3 residues / <50

        usable fold context with explicit model-confidence limits

        Near-complete coverage / observed 170 of 170 residues.

        • residues 128-149 / mean 55.72
        • residues 1-10 / mean 55.6
        • residues 164-170 / mean 59.46
        • residues 23-29 / mean 65.12
        proof debt register

        Visible limits, not hidden cleanup.

        21%

        Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.

        medium missing functional-site annotations link target annotation, GO term, or binding-site context
        low computational-only status add independent evidence, challenge result, or witness review before strengthening
        medium no candidate yet leave visible until a stronger public receipt resolves it

        weakness and challenge edges

        What would stop this from becoming stronger.

        debt severity export claim strength next proof needed
        missing functional-site annotations medium visible weakens link target annotation, GO term, or binding-site context
        computational-only status low visible watch add independent evidence, challenge result, or witness review before strengthening
        no candidate yet medium visible weakens leave visible until a stronger public receipt resolves it

        what supports it

        No upstream proof edge yet.

        what it supports

        target has structure prediction target:8494e70a-65b5-4eca-bbd3-1698dbd2a86a -> fold:c7d803d2-6895-4c39-9c41-96fbbc324c9c folds_to / B / 0.8

        Research-use boundary

        This receipt describes public computational research state. It does not expose raw candidate sequences and does not make a clinical claim.